What it sells
Rev is a biotechnology company creating better plants.
Business model breakdown
Workflow: what inputs become what output?
Genomic selection and tissue culture to develop cultivars, with molecular fingerprints for partners' strains.
Economics: what it saves and how it charges
Licenses cultivars and intellectual property; collaborates with partners on genomics and bioinformatics.
Distribution: how it reaches customers
Direct licensing and partnerships; cultivars commercialized in California.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2017 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.